UBS Group
NVACR

UBS Group’s NorthView Acquisition Corporation Rights NVACR Stock Holding History

UBS Group’s Portfolio NVACR Stock Details NVACR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-185
Closed -$19 – 10281
2024
Q2 		$19 Buy
+185
New +$24 ﹤0.01% 9312

Other funds holding NVACR

MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PL
Parkwood LLC Cleveland, Ohio $1.13B AUM 32.89% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
ASM
ATW SPAC Management New York $79.2M AUM 10.67% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

UBS Group's NVACR Position: Q3 2024 in Review

UBS Group sold out of NorthView Acquisition Corporation Rights (NVACR) in Q3 2024, closing a stake of 185 shares — an estimated $19 sold.

UBS Group first reported a position in NVACR in Q2 2024 and held it in 1 quarter. The position peaked at $19 in Q2 2024. 33 funds tracked by Wall St. Rank hold NVACR as of Q3 2024.

  • UBS Group reported no remaining NorthView Acquisition Corporation Rights position as of Q3 2024 after selling out during the quarter.
  • UBS Group sold 185 NorthView Acquisition Corporation Rights shares in Q3 2024, an estimated $19.
  • UBS Group first reported a position in NorthView Acquisition Corporation Rights in Q2 2024 and held it in 1 quarter.
  • UBS Group's NorthView Acquisition Corporation Rights position peaked at $19 in Q2 2024.
  • 33 funds tracked by Wall St. Rank held NorthView Acquisition Corporation Rights as of Q3 2024.

Based on UBS Group's 13F filing for Q3 2024, filed 14 Nov 2024.